Everything about Healthcare News
Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers with regards to the list rates of Wegovy and copyright when they pledge to maintain the medicines on their own formularies.The deal needs to be completed by Sept. t